HC Advisors’s Celldex Therapeutics CLDX Stock Holding History

HC Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$238K	Sell
2022 Q3	$341K	Buy
2022 Q2	$206K	Sell
2022 Q1	$261K	Sell
2021 Q4	$316K	Buy
2021 Q3	$296K	Sell
2021 Q2	$215K	Buy
2021 Q1	–	Sell
2020 Q4	$259K	Buy
2020 Q3	$187K	Buy